Antisense IAP nucleobase oligomers and uses thereof

Details Antisense IAP nucleobase oligomers and uses thereof Antisense IAP nucleobase oligomers and uses thereof

2006-06-30

2009-12-29

Vivlemore, Tracy (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S024500, C435S320100

Reexamination Certificate

active

07638497

ABSTRACT:
The present invention features nucleobase oligomers that hybridize to IAP polynucleotide, and methods for using them to enhance apoptosis and treat proliferative disorders.

REFERENCES:
patent: 5510239 (1996-04-01), Baracchini et al.
patent: 5576208 (1996-11-01), Monia et al.
patent: 5594076 (1997-01-01), Gordon et al.
patent: 5605022 (1997-02-01), Fulton
patent: 5624803 (1997-04-01), Noonberg et al.
patent: 5665550 (1997-09-01), Roninson et al.
patent: 5691179 (1997-11-01), Korsmeyer
patent: 5718883 (1998-02-01), Harlan et al.
patent: 5770690 (1998-06-01), Bitler et al.
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5834216 (1998-11-01), Roizman et al.
patent: 5919912 (1999-07-01), Korneluk et al.
patent: 5958771 (1999-09-01), Bennett et al.
patent: 5958772 (1999-09-01), Bennett et al.
patent: 5994076 (1999-11-01), Chenchik et al.
patent: 5998148 (1999-12-01), Bennett et al.
patent: 6020127 (2000-02-01), MacKenzie
patent: 6087173 (2000-07-01), Bennett et al.
patent: 6107041 (2000-08-01), Korneluk et al.
patent: 6133246 (2000-10-01), McKay et al.
patent: 6133437 (2000-10-01), Korneluk et al.
patent: 6156535 (2000-12-01), Korneluk et al.
patent: 6187557 (2001-02-01), Rothe et al.
patent: 6228603 (2001-05-01), Reed et al.
patent: 6265157 (2001-07-01), Prockop et al.
patent: 6300492 (2001-10-01), Korneluk et al.
patent: 6395771 (2002-05-01), Ramadoss et al.
patent: 6417160 (2002-07-01), Tatton et al.
patent: 6492427 (2002-12-01), Shankar et al.
patent: 6506559 (2003-01-01), Fire et al.
patent: 6656704 (2003-12-01), Korneluk et al.
patent: 6673917 (2004-01-01), Korneluk et al.
patent: 6946544 (2005-09-01), Korneluk et al.
patent: 7087584 (2006-08-01), Korneluk et al.
patent: 7091333 (2006-08-01), LaCasse et al.
patent: 7294713 (2007-11-01), Korneluk et al.
patent: 2002/0119168 (2002-08-01), Rudnic et al.
patent: 2002/0168631 (2002-11-01), Park et al.
patent: 2003/0073159 (2003-04-01), He et al.
patent: 2003/0190659 (2003-10-01), LaCasse et al.
patent: 2005/0153919 (2005-07-01), Paolo et al.
patent: 2343102 (2000-04-01), None
patent: 2353108 (2000-06-01), None
patent: 2480308 (2003-10-01), None
patent: WO 94/06814 (1994-03-01), None
patent: WO 95/19431 (1995-07-01), None
patent: WO 95/028497 (1995-10-01), None
patent: WO 95/30435 (1995-11-01), None
patent: WO 96/12016 (1996-04-01), None
patent: WO 96/12737 (1996-05-01), None
patent: WO 96/20950 (1996-07-01), None
patent: WO 96/35703 (1996-11-01), None
patent: WO 97/06182 (1997-02-01), None
patent: WO 97/06255 (1997-02-01), None
patent: WO 97/023501 (1997-07-01), None
patent: WO 97/26331 (1997-07-01), None
patent: WO 98/22131 (1998-05-01), None
patent: WO 98/022131 (1998-05-01), None
patent: WO 98/35693 (1998-08-01), None
patent: WO 00/05366 (2000-02-01), None
patent: WO 00/32816 (2000-06-01), None
patent: WO 00/32818 (2000-06-01), None
patent: WO 00/61595 (2000-10-01), None
patent: WO 01/18024 (2001-03-01), None
patent: WO 02/26968 (2002-04-01), None
patent: WO 03/076592 (2003-09-01), None
patent: WO 03/080638 (2003-10-01), None
patent: WO 2004/091388 (2004-10-01), None
patent: WO 2005/042030 (2005-05-01), None
Elbashir et al. EMBO Journal 2001, vol. 20, pp. 6877-6888.
Agrawal et al., “Antisense Therapeutics,”Curr. Opin. Chem. Biol. 2:519-528 (1998).
Andreeff et al., “Inhibitor-of-apoptosis (IAP) Proteins XIAP and Survivin in Primary Acute Myelogenous Leukemias (AML): Regulation and Therapeutic Targets,” Proceedings Annual Meeting of the American Association for Cancer Research,Abstract41:739-740 (2000).
Birnbaum et al., “An Apoptosis-inhibiting Gene From a Nuclear Polyhedrosis Virus Encoding a Polypeptide with Cys/His Sequence Motifs,”J. Virol. 68:2521-2528 (1994).
Branch, “A Good Antisense Molecule Is Hard To Find,”Trends Biochem. Sci. 23: 45-50 (1998).
Campbell, “Monoclonal Antibody Technology,” Elsevier Science, Publishers B.V. New York, NY, (1984).
Cheng et al., “Characterisations of Taxol-induced Apoptosis and Altered Gene Expression in Human Breast Cancer Cells,”Cellular Pharmacol. 2: 249-257 (1995).
Cheng et al., “Staurosporine, K-252a, And K-252b Stabilize Calcium Homeostasis and Promote Survival of CNS Neurons in the Absence of Glucose,”J. Neurochem. 62:1319-1329 (1994).
Chirila et al., “The Use of Synthetic Polymers for Delivery of Therapeutic Antisense Oligodeoxynucleotides,”Biomaterials23: 321-342 (2002).
Clem et al., “Prevention of Apoptosis by a Baculovirus Gene During Infection of Insect Cells,”Science254:1388-1390 (1991).
Clem et al., “Control of Programmed Cell Death by the Baculovirus Genesp35Andiap,” Mol. Cel. Biol. 14:5212-5222 (1994).
Clem et al., “Anti-apoptotic Genes of Baculoviruses,”Cell Death and Differentiation3:9-16 (1996).
Crook et al., “An Apoptosis-inhibiting Baculovirus Gene with a Zinc Finger-like Motif,”J. Virol. 67:2168-2174 (1993).
Dhein et al., “Autocrine T-cell Suicide Mediated by APO-1/(Fas/CD95),”Nature373:438-441 (1995).
Dierlamm et al., “The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene, MLT, Are Recurrently Rearranged in the t(11 ;18)(q21;q21) Associated with Mucosa-Associated Lymphoid Tissue Lymphomas,”Blood93: 3601-3609 (1999).
Duckett et al., “A Conserved Family of Cellular Genes Related to the Baculovirus IAP Gene and Encoding Apoptosis Inhibitors,”EMBO J. 15:2685-2694 (1996).
Erl et al., “Nuclear Factor-kappa B Regulates Induction of Apoptosis and Inhibitor of Apoptosis Protein-1 Expression in Vascular Smooth Muscle Cells,”Cir. Res. 84:668-677 (1999).
Fallo et al., “Effects of Taxol on the Human NCI-H295 Adrenocortical Carcinoma Cell Line,”Endocr. Res. 22: 709-715 (1996).
Fernandez et al., “Differential Sensitivity of Normal and Ha-ras-transformed C3H Mouse Embryo Fibroblasts to Tumor Necrosis Factor: Induction of bcl-2, c-myc, and Manganese Superoxide Dismutase in Resistant Cells,”Oncogene9:2009-2017 (1994).
Ferrari et al., “N-acetylcysteine (D- and L-stereoisomers) Prevents Apoptotic Death of Neuronal Cells,”J. Neurosci. 15:2857-2866 (1995).
Fisher et al., “Dominant Interfering Fas Gene Mutations Impair Apoptosis in a Human Autoimmune Lymphoproliferative Syndrome,”Cell81:935-946 (1995).
Francis et al., “The Response Of GABAergic and Cholinergic Neurons to Transient Cerebral Ischemia,”Brain Res. 243:271-278 (1982).
Galderisi et al., “Antisense Oligonucleotides as Therapeutic Agents,”J. Cell. Physio. 181: 251-257 (1999).
Gewirtz, “Antisense Oligonucleotide Therapeutics for Human Leukemia,”Curr. Opin. Hematol. 5 : 59-71 (1998).
Gibellini et al., “Tat-expressing Jurkat Cells Show an Increased Resistance to Different Apoptotic Stimuli, Including Acute Human Immunodeficiency Virus-type 1 (HIV-1) Infection,”Br. J. Haematol. 89:24-33 (1995).
Glicksman et al., “K-252a and Staurosporine Promote Choline Acetyltransferase Activity in Rat Spinal Cord Cultures,”J. Neurochem. 61:210-221 (1993).
Glicksman et al., “A K-252a Analog Prevents Developmentally Programmed Motoneuron Death and the Loss of Chat Activity in Adult Motoneurons In Vivo,”Soc. Neuro. Abst. 441 (1994).
Glicksman et al., “K-252a Promotes Survival and Choline Acetyltransferase Activity in Striatal and Basal Forebrain Neuronal Cultures,”J. Neurochem. 64:1502-1512 (1995).
Golstein et al., “Homology Between Reaper and the Cell Death Domains of Fas and TNFR1,”Cell81:185-186 (1995).
Goruppi et al., “Dissection of c-myc Domains Involved in S Phase Induction of NIH3T3 Fibroblasts,”Oncogene9:1537-1544 (1994).
Harrington et al., “c-Myc-induced Apoptosis in Fibroblasts is inhibitied by Specific Cytokines,”EMBO J. 13:3286-3295 (1994).
Holcik, et al. “Translational Upregulaton of X-Linked Inhibitor of Apoptosis (XIAP) Increases Resistance to Radiation Induced Cell Death,”Oncogene19:4174-4177 (2000).
Holc

Affiliated with

Also associated with

Rating

Antisense IAP nucleobase oligomers and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense IAP nucleobase oligomers and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense IAP nucleobase oligomers and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4114930